Recurrent Hepatitis C Post-Liver Transplant Replication Matters

McCashland, T. M.; Thompson, Jon S.
January 2001
American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p5
Academic Journal
Presents information on the study "Hepatitis C-induced Hepatic Allograft Injury is Associated With a Pretransplantation Elevation of Viral Replication Rate," by S. J. Pelletier, D. P. Raymond, T. D. Crabtree et al.


Related Articles

  • Early Evolution of Hepatitis C Virus(HCV) Quasispecies after Liver Transplant for HCV-Related Disease. Schvoerer, Evelyne; Soulier, Eric; Royer, Cathy; Renaudin, Anne-Catherine; Thumann, Christine; Fafi-Kremer, Samira; Brignon, Nicolas; Doridot, Stéphane; Meyer, Nicolas; Pinson, Patricia; Ellero, Bernard; Woehl-Jaegle, Marie-Lorraine; Meyer, Carol; Wolf, Philippe; Zachary, Pierre; Baumert, Thomas; Stoll-Keller, Françoise // Journal of Infectious Diseases;8/15/2007, Vol. 196 Issue 4, p528 

    Background. End-stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant...

  • A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Ikegami, Toru; Shirabe, Ken; Yoshiya, Shohei; Yoshizumi, Tomoharu; Yamashita, Yo-ichi; Harimoto, Norifumi; Toshima, Takeo; Uchiyama, Hideaki; Soejima, Yuji; Maehara, Yoshihiko // Surgery Today;Feb2014, Vol. 44 Issue 2, p233 

    Purpose: The feasibility of performing living donor liver transplantation (LDLT) for patients with high end-stage liver disease (MELD) scores needs to be assessed. Methods: A total of 357 patients who underwent LDLT were included in this analysis. Results: Overall, 46 patients had high MELD...

  • Treatment of Hepatitis C in Solid Organ Transplantation. Chan, Susan E.; Schwartz, Jonathan M.; Rosen, Hugo R. // Drugs;2004, Vol. 64 Issue 5, p489 

    Hepatitis C virus (HCV) infection is highly prevalent worldwide, and results in significant morbidity and mortality. HCV frequently infects haemodialysis patients and appears to impact on long-term survival of kidney transplant recipients. Therefore, treatment is recommended for kidney...

  • Frozen cancellous bone allografts: positive cultures of implanted grafts in posterior fusions of the spine. Barriga, A.; Díaz-de-Rada, P.; Barroso, J. L.; Alfonso, M.; Lamata, M.; Hernáez, S.; Beguiristáin, J. L.; San-Juliá;n, M.; Villas, C. // European Spine Journal;Mar2004, Vol. 13 Issue 2, p152 

    We have carried out a study on the behaviour pattern of implanted allografts initially stored in perfect conditions (aseptically processed, culture-negative and stored at -80 °C) but which presented positive cultures at the implantation stage. There is no information available on how to deal...

  • The impact of hepatitis C virus infection on renal allograft recipients. Roth, David; Zucker, Keith; Cirocco, Robert; DeMattos, Angelo; Burke, George W.; Nery, Jose; Esquenazi, Violet; Babischkin, Sharon; Miller, Joshua // Kidney International;Jan1994, Vol. 45 Issue 1, p238 

    A second generation hepatitis CT virus recombinant immunoblot assay (RIBA) was used to screen stored perioperative serum from 641 renal allograft recipients. One hundred and nine (17%) were anti-HCV positive at the time of transplant. RIBA positivity was found to be an independent predictor of...

  • Poorer Outcomes for Recipients of Heart Allografts From HCV-Positive Donors. Qamar, Amir A.; Rubin, Robert H. // JAMA: Journal of the American Medical Association;10/18/2006, Vol. 296 Issue 15, p1900 

    The article discusses organ transplant patients and the outcomes of those that receive hepatitis C virus-infected (HCV) hearts. Chronic anti-rejection therapy has been widely used during the past 30 years in transplant patients as a means to fight off infections and allograft rejections. There...

  • Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duetâ„¢) combined morphological and cytogenetical response. Shimoni, A.; Nagler, A. // Leukemia (08876924);Aug2002, Vol. 16 Issue 8, p1413 

    Recurrent disease remains a major obstacle to cure after allogeneic transplantation. Various methods have been developed to detect minimal residual disease (MRD) after transplantation to identify patients at risk for relapse. Chimerism tests differentiate recipient and donor cells and are used...

  • New approach to organ transplantation based on the fetal allograft. Finn, Ronald; Hill, C.A.St. // British Medical Journal;6/24/1978, Vol. 1 Issue 6128, p1671 

    A new approach to organ transplantation that may be particularly applicable to kidney transplantation is suggested by analogy with the immunological mechanism responsible for the survival of the fetal allograft. The method concerns identifying donor-recipient tissue compatibility by use of the...

  • The Irradiated Hamster Test. Streilein, J. Wayne; Hildreth, E.A.; Ramseder, H.; Kornblum, J. // Annals of Internal Medicine;Sep66, Vol. 65 Issue 3, p511 

    Examines the Irradiate Hamster Test, a method of donor selection for homotransplantation in man. Materials and methodology of the study; Cutaneous reactions evoked by inoculation of human lymphoid cells; Comparison of reaction scores induced by lymphocyte mixtures with skin homograft survival...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics